CSMD3 was mutated in five samples from the present study (14% of cases, comprising 2/8 POSV595E and 3/28 UDV595E samples), and was also highlighted as a recurrently mutated gene in bladder cancers of both dogs and people [14]. This evidence concerns the gene CSMD3 and urinary bladder carcinoma.